Clinical Trial Update: Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome [NA]

View source ↗

Summary

A clinical trial investigates the combination of metformin with a drospirenone/ethinylestradiol 30 µg oral contraceptive and its effect on flow-mediated dilatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Polycystic Ovary Syndrome

Drugs mentioned

• Drospirenone/ethinylestradiol 30 µg (drospirenone/ethinylestradiol)
• metformin (metformin)

Snippet

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy | Conditions: Polycystic Ovary Syndrome, Endothelial Dysfunction | NA | Status: UNKNOWN